FDA Clearance: Page 2

Abionic nabs IVDR certification for sepsis test
The device detects pancreatic stone protein, an early marker for sepsis, allowing for its identification in about five minutes, Abionic said.
August 8, 2022
2020 06 19 20 57 0712 Sepsis Bacteria 400
Video from AACC: Cytovale immune-response test for sepsis
The San Francisco-based startup has submitted an application to the U.S. Food and Drug Administration (FDA) for clearance of the system and test, which aims to help emergency departments to more effectively and quickly triage patients.
July 28, 2022
2022 07 29 16 04 7496 Shah 400
FDA clears Angle’s Parsortix breast cancer system
The FDA clearance is the first FDA product clearance to harvest cancer cells from a blood sample for subsequent analysis. This offers the prospect of a new era of personalized cancer care, according to the company.
July 27, 2022
2022 07 28 17 23 1016 Breast Biopsy Mammotome 400
Siemens Healthineers unveils in vitro diagnostics systems at AACC 2022
The system, with the capacity to conduct more than 250,000 clinical chemistry tests per year and more than 25,000 immunoassay tests per year, is in development and under review for potential clearance by the U.S. Food and Drug Administration (FDA), the firm said.
July 26, 2022
2022 07 27 14 51 5076 Doctor Analysis Clinical Samples 400
DiaSorin nabs FDA clearance for infectious disease blood test
The fully automated test utilizes host response-based data to enable physicians to differentiate accurately between bacterial and viral infections, supporting faster and better-informed treatment and patient management decisions, DiaSorin said.
July 21, 2022
2020 08 27 17 11 6347 Infectious Diseases Research 400
Exact Sciences subsidiary nabs FDA clearance for CDx
The CDx confirms variants in POMC, PCSK1, or LEPR genes that are interpreted as pathogenic, likely pathogenic, or of uncertain significance.
June 29, 2022
2019 05 22 19 44 5254 Dna Red Laser 400
Most Popular
Researchers find hidden bacteria that pose antimicrobial resistance risk to hospital patients
Quest Diagnostics Q4 revenues down 15% on COVID testing but base business grew
SD Biosensor, SJL Partners complete acquisition of Meridian Bioscience
OIG report outlines challenges with CDC-supported COVID-19 vaccination programs
Duke University developing blood test to detect osteoarthritis progression in the knee
Roche reports flat diagnostics revenue growth for 2022
Sysmex nabs FDA clearance for addition to analyzer
The analyzer also supports red blood cell and platelet component testing in a single sample aspiration, providing blood processing centers with increased efficiency, consistency, and accuracy, the firm said.
June 14, 2022
2022 06 15 18 37 7431 Xn 1000 Bb Thumbnail
FDA grants approval for Fujirebio assay for Alzheimer's plaques
The FDA granted clearance under its breakthrough device pathway to Fujirebio's Lumipulse G β-Amyloid Ratio (1-42/1-40) test, which is designed to measure the ratio of β-amyloid 1-42 and β-amyloid 1-40. These are proteins that can accumulate and form plaques in the brain; concentrations of these proteins can be detected in cerebral spinal fluid (CSF).
May 3, 2022
2022 05 04 20 54 3251 Computer Brain Hemisphere 400
FDA clears COVID-19 test based on breath samples
The InspectIR COVID-19 breathalyzer test provides results in less than three minutes, according to an FDA news release. It is the first COVID-19 breathalyzer test to receive FDA clearance, with others in development.
April 14, 2022
2019 02 13 19 24 5396 Fda Logo V2 400
Foundation Medicine nabs FDA clearance for NSLC diagnostic
The test received FDA clearance in February for identifying patients with microsatellite instability-high solid tumors who may benefit from pembrolizumab (Keytruda) treatment. FoundationOne CDx can now also be used as a companion diagnostic to identify patients with NSCLC whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L858R) alterations.
March 17, 2022
2019 10 09 17 32 0093 Dna Cancer Cell 400
Immunexpress sepsis test gets FDA 510(k) clearance
SeptiCyte Rapid uses reverse transcription polymerase chain reaction to quantify directly from blood the relative expression of genes involved in a patient's immune response, the company said.
November 29, 2021
2019 02 13 19 24 5396 Fda Logo V2 400
BD secures BARDA funds for development of COVID-19 test
Under terms of the deal, BARDA will extend its support to BD by up to $40.3 million for the development and U.S. Food and Drug Administration (FDA) clearance of five new tests:
November 1, 2021
2019 08 20 21 56 4986 Becton Aacc 2019 400
Previous Page
Page 2 of 5
Next Page